Sangamo Therapeutics
SGMO
#10549
Rank
NZ$56.04 M
Marketcap
NZ$0.14
Share price
0.00%
Change (1 day)
-80.60%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$34.55 Million. In 2025 the company made an earning of -NZ$0.2 Billion a decrease over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.19 Billion-4.14%
2025 -NZ$0.2 Billion9.71%
2024 -NZ$0.18 Billion-17.27%
2023 -NZ$0.22 Billion-40.88%
2022 -NZ$0.37 Billion9.79%
2021 -NZ$0.34 Billion41.52%
2020 -NZ$0.24 Billion23.17%
2019 -NZ$0.2 Billion36.33%
2018 -NZ$0.15 Billion36.89%
2017 -NZ$0.11 Billion-22.32%
2016 -NZ$0.14 Billion54.86%
2015 -NZ$85.66 Million75.62%
2014 -NZ$48.78 Million0.13%
2013 -NZ$48.71 Million
2011 -NZ$65.49 Million43.66%
2010 -NZ$45.59 Million28.52%
2009 -NZ$35.47 Million-23.55%
2008 -NZ$46.4 Million2.45%
2007 -NZ$45.29 Million19.5%
2006 -NZ$37.9 Million50.78%
2005 -NZ$25.14 Million75%
2004 -NZ$14.37 Million-33.25%
2003 -NZ$21.52 Million-62.27%
2002 -NZ$57.03 Million102.82%
2001 -NZ$28.12 Million23.21%
2000 -NZ$22.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.20 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$0.81 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$0.78 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-NZ$4.64 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.28 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.23 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$79.81 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA